Veterinary Molecular Diagnostics Market, By Product (Consumables (Leukemia, Influenza), System and Software), By Technology (ELISA, PCR and Hematology), By Animal Type (Canine, Feline, Swine, Bovine and Poultry), By End-User (Point of Care Testing and Veterinary Hospital) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Veterinary Molecular Diagnostics Market accounted for US$ 2.98 billion in 2020 and is estimated to be US$ 5.36 billion by 2030 and is anticipated to register a CAGR of 6.10%.

Veterinary molecular diagnostics is a cutting-edge technology that can be used to diagnose animal diseases accurately and quickly. On the basis of previous experiences, ongoing research efforts, clinical manifestations, and other factors, it provides a deeper understanding. Veterinary molecular diagnostics is a technique for detecting, diagnosing, and monitoring diseases in animals using DNA-based testing. Many farm animals, such as cattle, swine, fowl, sheep, and goats, now undergo routine veterinary genetic testing. This method not only aids in the eradication of outbreaks, but also aids in the prevention of future infections by monitoring pathogens before they spread, ensuring the use of effective vaccines, and providing information on how resistant viruses have become so that veterinarians can adjust their strategy accordingly.

Impact of Covid-19 pandemic on market

As the COVID-19 outbreak continues to wreak havoc on global markets, the veterinary diagnostics market will be impacted in the next years as more veterinary diagnostics solutions for animal protection and diagnosis are developed. In numerous nations, a limited number of pet cats and dogs have been infected with the virus. SARS-CoV-2 infections have been documented in a small number of animals around the world, mostly in those that came into close contact with a COVID-19-infected person.

                            Rising prevalence of foodborne and zoonotic diseases

Rising prevalence of foodborne and zoonotic diseases, increasing animal population, increasing demand for animal-derived food products, and favorable government campaigns conducted in these regions, emerging countries in the Asia-Pacific region offer high growth opportunities for veterinary diagnostic manufacturers. According to the International Livestock Research Institute (ILRI), India has a significant zoonotic disease burden, as do low-income nations like Ethiopia, Nigeria, and Tanzania. In India, animal pathogens account for 60% of all disease-causing pathogens, while zoonotic illnesses account for 75% of new infectious diseases. As a result, rising disease outbreaks in developing countries are pushing need for better animal diagnostics in order to avoid economic losses.

In addition, governments in poorer nations are launching a number of initiatives and schemes to control animal illness epidemics. For example, Shandong University approved a proposal in August 2018 to establish an Eco health/One Health Institute in China, which will include Chinese and international professionals working in a variety of veterinary and environmental health fields. The goal of establishing an Eco health/One Health Institute in China is to address large and complicated animal health issues in the country.

Veterinary Molecular Diagnostics Market report segments the market on the basis of product, technology, animal type, end-user and region.

On the basis of Product, the  Veterinary Molecular Diagnostics Market is segmented into Consumables (Leukemia, Influenza), System and Software. On the basis of Technology, the target market is segmented into ELISA, PCR and Hematology. On the basis of Animal Type, the target market is segmented into Canine, Feline, Swine, Bovine and Poultry. Based on End-User, the market is segmented into Point of Care Testing and Veterinary Hospital.

Regional Insights:

Veterinary Molecular Diagnostics Market accounted for US$ 2.98 billion in 2020 and is estimated to be US$ 5.36 billion by 2030 and is anticipated to register a CAGR of 6.10%. On region the Veterinary Molecular Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Over the projection period, the veterinary molecular diagnostics market in North America is expected to hold the biggest share. Furthermore, the North American region is predicted to increase at the fastest rate during the forecast period. This is because to the expanding trend of pet ownership in the region, as well as the increased need for animal-based proteins. Due to factors such as expanding pet adoption and rising per capita animal healthcare expenditure, the United States is likely to maintain its considerable market share. Furthermore, the rise in the occurrence of numerous animal diseases and injuries has been cited as a major driver of market expansion.

Veterinary Molecular Diagnostics Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Veterinary Molecular Diagnostics Market report based on product, technology, animal type, end-user and Region.

Veterinary Molecular Diagnostics Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the Veterinary Molecular Diagnostics Market includes DEXX Laboratories, Inc., NeoGenomics Laboratories, Inc., Abaxis, Heska Corporation, Zoetis, Thermo Fisher Scientific, Inc., Virbac, CAREVET, Agfa-Gevaert Group., Veterinary Molecular Diagnostics, Inc.,  Novacyt Group, Qiagen, AT Veterinary Systems Ltd., Animage LLC, Veterinary Laboratory - HealthGene Corp., Ingenetix, INDICAL BIOSCIENCE GmbH, bioMérieux SA., Core Imaging LLC, and Quality Vet Lab among other domestic and global players.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is a scientific instrumentation, reagents and consumables, and software Services Company based in the United States. The TaqMan™ Salmonella Enteritidis Detection Kit is part of a comprehensive workflow that enables users to rapidly detect Salmonella Enteritidis in poultry egg and environmental samples.

• The National Veterinary Services Laboratories (NVSL) of the United States Department of Agriculture (USDA) announced the first verified case of SARS-CoV-2 (the virus that causes COVID-19) infection in a domestic dog (German shepherd) in New York state in June 2020. This is the first dog to test positive for SARS-CoV-2 in the United States.
• The Centers for Disease Control and Prevention (CDC) and the National Veterinary Services Laboratories (NVSL) of the United States Department of Agriculture (USDA) announced verified cases of SARS-CoV-2 (the virus that causes COVID-19) infection in two pet cats in April 2020.

• DEXX Laboratories, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• NeoGenomics Laboratories, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Abaxis
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Heska Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Zoetis
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Virbac
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• CAREVET
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Agfa-Gevaert Group
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Veterinary Molecular Diagnostics, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies